Aardema, M.J. & MacGregor, J.T. (2002): Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat. Res. 499: 13-25.

Balbus, J.M. (2005): Ushering in the new toxicology: toxicogenomics and the public interest. Environ Health Perspect. Jul;113(7): 818-22.

Barns, I., Schibeci, R., Davison, A., & Shaw, R. (2000): What do you think about genetic medicine?: facilitating sociable public discourse on developments in the New Genetics. Science Technology and Human Values, 25 (3), 283-308.

BUWAL – Röösli, M. & Rapp, R. (2003): Hochfrequente Strahlung und Gesundheit (BUWAL Umwelt-Materialien Nr. 162). Bern, Schweiz: Bundesamt für Umwelt, Wald und Landschaft (BUWAL).

Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L. & Legius, E. (2004): Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation. Genet Test, 8(1), 13-21.

Denayer, L., Welkenhuysen, M., Evers-Kiebooms, G., Cassiman, J.J. & Van den Berghe, H. (1997): Risk perception after CF carrier testing and impact of the test result on reproductive decision making. Am J Med Genet, 69(4), 422-428.

EPA (1999): Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum, U.S. Environmental Protection Agency. Washington, DC.

EPA (2000a): Risk characterization handbook. US Environmental Protection Agency: Washington, DC.

EPA (2000b): Toward Integrated Environmental Decision-making. See: http://www.epa.gov/sab/pdf/
ecirp011.pdf.

EC European Commission (2000a), Commission of the European Communities, Communication on the Precautionary Principle, Brussels 02 February 2000. See http://europa.eu.int/comm/off/com/
health_consumer/precaution.htm.

EC European Commission (2000b): First Report on the Harmonisation of Risk Assessment Procedures. Brussels: European Commission; Scientific Committee's Working Group; Directorate C.

Gigerenzer, G. (2002): Reckoning with risk: learning to live with uncertainty. London: Penguin.

Gigerenzer, G. & Edwards, A. (2003): Simple tools for understanding risks: from innumeracy to insight. BMJ, 327(7417), 741-744.

IARC (2002): Non-Ionizing Radiation, Part 1: Static and Extremely Low-Frequency (ELF) Electric and Magnetic Fields. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans and their Supplements, Vol. 80.

ICNIRP (2005): International Commission on Non-Ionizing Radiation Protection ICNIRP – 2004/2005 REPORT.http://www.icnirp.de/documents/annualreport2005.pdf.

IEGMP (2000): Mobile Phones and Health. Chilton, UK: Independent Expert Group on Mobile Phones. National Radiological Protection Board.

Genomics Momentum (2004): Genomics for our world. http://www.genomics.nl/homepage/publications/Synopsis_GM04.pdf.

Genomforschung in Österreich (2005) see http://www.gen-au.at/programm.jsp

German Genome Project (2004) see http://www.dhgp.de/deutsch/forschung/index.html

Gordon, T.J. & Helmer, O. Report on a Long Range Forecasting Study. RAND Paper P-2982. (RAND Corporation, Santa Monica, California, USA, 1964).

Goldstein, B.D. (2005): Advances in risk assessment and communication. Annu Rev Public Health, 26, 141-163.

Henry C.J. et al. (2002): Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop. Environ Health Perspect. Oct; 110(10):1047-50.

Joss, S. & Bellucci, S, eds. (2002): Participatory Technology Assessment - European Perspectives. London: CSD.

Kraus, N., Malmfors, T. & Slovic, P. (1992): Intuitive toxicology: Expert and lay judgments of chemical risk. Risk Analysis, 12(2), 215-232.Linstone, H. & Turoff, M., eds. (1975): The Delphi Method – Techniques and Applications. Addison-Wesley, Massachusetts, USA.

Lippman-Hand, A. & Fraser, F.C. (1979): Genetic counseling - the postcounseling period: I. Parents' perceptions of uncertainty. American Journal of Medical Genetics, 4, 51-71.

MacGregor D.G., Slovic P. & Malmfors T. (1999): How exposed is exposed enough?" Lay inferences about chemical exposure. Risk Analysis, 19(4): 649-59

Marchant, G. (2003): Genomics and Toxic Substances: Part II – Toxicogenetics, 33 Environmental Law. Rep. 10641-10667

Mertz C.K., Slovic P. & Purchase I.F. (1998): Judgments of chemical risks: comparisons among senior managers, toxicologists, and the public. Risk Analysis, 18(4): 391-404

Niewöhner, J., Wiedemann, P., Karger, C., Schicktanz, S., Tannert, C. (2005): Participatory prognostics in Germany – developing lay scenarios for the relationship between biomedicine and the economy in 2014. Technological Forecasting and Social Change, 72 ,2, 195 – 211.

Niewöhner, J. & Tannert, C. (2005): „Online-Diskurs zu den ethischen Fragen der Biomedizin.“ Zschr. Biopolitik 4 (1), 53-63.

NHMRC (2000): How to use the evidence: Assessment and application of scientific evidence. National Health and Medical Research Council. http://www.nhmrc. health.gov.au/publications/ pdf/cp69.pdf).

NRC – National Research Council (1994): Science and judgment in risk assessment. Washington, DC: National Academy Press.

NRPB (2003): Health effects from radiofrequency electromagnetic fields. Report of an independent Advisory Group on Non-ionising Radiation (Doc NRPB, 14(2)). Chilton, UK: National Radiological Protection Board.

Neutra, R., DelPizzo, V. & Lee, G.M. (2002). An evaluation of the possible risks from electric and magnetic fields (EMFs) from power lines, internal wiring, electrical occupations and appliances (Final Report). Oakland, CA: California EMF Project. www.dhs.ca.gov/ehib/emf/RiskEva­luation/riskeval.html.

Office of Science and Technology and the Wellcome Trust, eds (2000): Science and the Public.A Review of Science Communication and Public. Attitudes to Science in Britain. A Joint Report by the Office of Science and Technology and the Wellcome Trust.

Pennie, W., Pettit, S.D. & Lord, P.G. (2004): Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. Environ Health Perspect, 112: 417-419

Pew Research Center (2002): Public makes distinctions on genetic research, US survey, February 25 - March 10, 2002, http://people-press.org/reports/display.php3?PageID=409.

Reitz, F., Barth, J. & Bengel, J. (2004): Predictive value of breast cancer cognitions and attitudes toward genetic testing on women's interest in genetic testing for breast cancer risk. Psycho-Social-Medicine, 1, Doc 3; http://www.egms.de/en/journals/psm/2004-1/psm000003.shtml.

Reflex Study: http://europa.eu.int/comm/research/quality-of-life/ka4/ka4_electromagnetic_en.html#
case2.

Salerno, R.A. & Lesko, L.J. (2004b): Pharmacogenomics in drug development and regulatory decision-making: the Genomic Data Submission (GDS) proposal. Pharmacogenomics, 5(1):25-30.

Scarfì, M.R. (2001): Genotoxic effects of both elf and radiofrequency alone and in combination with exposure to chemicals. Paper presented at the Conference "Genetic Susceptibility At Low Dose Exposure". 31st Annual Meeting of the European Environmental Mutagen Society, September 1 - 5, 2001, Ghent, Belgium.

Schmidt, C.W. (2002): Toxicogenomics: an emerging discipline. Environ Health Perspect., 110(12): A750-5.

Schmidtke, Jörg & Sperling, K. (2003): Genetische Tests auf dem Teststand. Zf Biopolitik 2, 39-47.

Schütz, H. & Wiedemann, P.M. (2005): How to deal with dissent among experts. Risk evaluation of EMF in a scientific dialogue Journal of Risk Research, 8, 6, 531 - 545

Schütz, H., Wiedemann, P.M., Hennings, W., Mertens, J. & Clauberg, M. (2004): Vergleichende Risikobewertung. Konzepte, Probleme, Anwendungsmöglichkeiten (Reihe Umwelt / Environment 45). Jülich: Forschungszentrum Jülich GmbH

Simmons, P.T. & Portier, C.J. (2002): Toxicogenomics: the new frontier in risk analysis. Carcinogenesis 23: 903-905.

Slovic, P., Malmfors, T., Krewski, D., Mertz, C.K. & et al. (1995): Intuitive toxicology. II. Expert and lay judgments of chemical risks in Canada. Risk Analysis, 15(6), 661-675.SSK (2001): Grenzwerte und Vorsorgemaßnahmen zum Schutz der Bevölkerung vor elektromagnetischen Feldern – Empfehlungen der Strahlenschutzkommission. Bonn: Strahlenschutz­kommission.

Streffer, C., Bolt, H., Follesdal, D., Hall, P., Hengstler, J.G., Jacob, P., Oughton, D., Prieß, K., Rehbinder, E. & Swaton, E. (2004): Low Dose Exposures in the Environment. Dose-Effect Relations and Risk Evaluation. Berlin: Springer.

Voss, A. (2002): E-discourses with Zeno, Fraunhofer AIS, Sankt Augustin.

Voss, H. (2000): Report to the Human Genetics Commission on public attitudes to the uses of human genetic information. http://www.hgc.gov.uk/UploadDocs/DocPub/Document/public_attitudes.pdf.

Welkenhuysen, M., Evers-Kiebooms, G. & d'Ydewalle, G. (2001): The language of uncertainty in genetic risk communication: framing and verbal versus numerical information. Patient Educ Couns, 43(2), 179-187.

WHO/OMS (2004): Framework to develop precautionary measures in areas of scientific uncertainty. Draft. October 2004.

Wiedemann, P.M., Simon, J., Schicktanz, S., Tannert, C. (2004): The future of stem cell research in Germany. EMBO-Reports 5, 927-931.

Wiedemann, P.M.; Schütz, H. & Spangenberg , A., eds. (2005): Risikobewertung Mobilfunk, Ergebnisse eines wissenschaftlichen Dialogs. Forschungszentrum Jülich GmbH: Reihe Umwelt, Band 54.

Wienhöfer, E. & Beckmann, J. (1998): Internetgestützter Diskurs zur Technikfolgenbewertung. Rep. 104, TA Stuttgart, Stuttgart.